Erythrokeratoderma
Erythrokeratodermia variabilis (EKV) is a rare subtype of heterogeneous group of skin diseases called the erythrokeratodermi, and presents with migratory erythema and fixed hyperkeratotic plaques. EKV lesions commonly occur in the early stage of life. The lesions are hyperkeratotic and well-marinated and have a tendency to become confluent. EKV lesions are usually distributed on the extensor surface of extremities, buttocks, and face. Erythematosus lesions are transitory and show variation with
stress and heat.[2] Two patients aged 10 and 15 years were evaluated for erythematous and hyperkeratotic lesions that were clinically and histopathologicallyconfirmed with EKV. We report these cases due to their rarity.A 10-year-old boy came to our clinic for brownish and red spots that had started 5 years ago and had appeared from time to time. The red spots initially spread centrifugally and disappeared without any mark, however, the brownish lesions on the anterior part of trunk and arms did not disappear. He was seen by different physicians and was treated with various
fungal treatments that were not beneficial. No similar lesions were detected in other family members. No systemic disease was detected.The dermatological examination showed erythematous, annular plaques located on the anterior part of chest, arms, and neck; and brownish hyperkeratosis plaques on the left shoulder.
High Impact List of Articles
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Macrolide therapy in cystic fibrosis: new developments in clinical use
K Frayman,P Robinson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Macrolide therapy in cystic fibrosis: new developments in clinical use
K Frayman,P Robinson
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Bioabsorbable stents-nothing from something
NS Rajendra, BJ Wrigley, AH Gershlick
Special Report: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Assessment of suicidal ideation and behavior in clinical trials: challenges & controversies
Glenn Melvin
Clinical Trail Perspective: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Role of ticagrelor in the treatment of coronary artery disease
Udaya S Tantry, Dean J Kereiakes, Paul A Gurbel
Review Article: Clinical Investigation
-
Role of ticagrelor in the treatment of coronary artery disease
Udaya S Tantry, Dean J Kereiakes, Paul A Gurbel
Review Article: Clinical Investigation
Relevant Topics in Clinical